ER Positive, HER2 Negative Breast Cancer trials recruiting in Tennessee

Fewer than 3 recruiting trials found.

All ER Positive, HER2 Negative Breast Cancer trials nationally

Cities in Tennessee

Recruiting trials in Tennessee

• A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
  NCT07647328 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female) · Tennessee: Nashville